Moleculin Biotech, Inc. (MBRX)
NASDAQ: MBRX · IEX Real-Time Price · USD
4.315
-0.155 (-3.47%)
At close: Jul 19, 2024, 4:00 PM
4.310
-0.005 (-0.12%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Moleculin Biotech Market Cap
Moleculin Biotech has a market cap or net worth of $9.97 million as of July 22, 2024. Its market cap has decreased by -41.33% in one year.
Market Cap
9.97M
Enterprise Value
-6.40M
1-Year Change
-41.33%
Ranking
Category
Stock Price
$4.32
Market Cap Chart
Since June 2, 2016, Moleculin Biotech's market cap has decreased from $70.70M to $9.97M, a decrease of -85.89%. That is a compound annual growth rate of -21.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 10.00M | -60.94% |
| Dec 29, 2023 | 25.60M | -15.51% |
| Dec 30, 2022 | 30.30M | -43.05% |
| Dec 31, 2021 | 53.20M | 6.83% |
| Dec 31, 2020 | 49.80M | 19.14% |
| Dec 31, 2019 | 41.80M | 48.23% |
| Dec 31, 2018 | 28.20M | -28.24% |
| Dec 29, 2017 | 39.30M | 42.91% |
| Dec 30, 2016 | 27.50M | -61.10% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mustang Bio | 10.94M |
| Traws Pharma | 10.92M |
| Inhibikase Therapeutics | 10.82M |
| Coeptis Therapeutics | 10.62M |
| MIRA Pharmaceuticals | 10.18M |
| ABVC BioPharma | 9.95M |
| Plus Therapeutics | 9.93M |
| Tonix Pharmaceuticals Holding | 9.78M |